Boardroom Alpha
Boardroom Alpha
TGT · Current Report (Form 8-K) · Filed June 12, 2026

Target Corp — Current Report (Form 8-K)

Form
8-K
Filed
June 12, 2026
Period
Jun 10, 2026
Ticker
TGT
Accession
0000027419-26-000026
Boardroom Alpha · Filing insights

Shareholders approved the 2026 LTIP restatement and executive compensation, elected 12 directors, and rejected three shareholder proposals.

About Target Corp
Market cap
$74.1B
1Y TSR
+59.3%
3Y TSR
+10.5%
Board grade
C+
Sector
Consumer Defensive
CEO
Michael J Fiddelke
Last annual meeting: Jun 10, 2026 · View full Target Corp profile →
tgt-20260610

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 10, 2026

Target Corporation
(Exact name of registrant as specified in its charter)
Minnesota 1-6049 41-0215170
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

1000 Nicollet Mall,Minneapolis,Minnesota

55403
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (612) 304-6073

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0833 per shareTGTNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 10, 2026, Target Corporation (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”). at which the Company’s shareholders approved the Amended and Restated Target Corporation 2020 Long-Term Incentive Plan (the “2026 Restatement”). The full text of the 2026 Restatement is attached hereto as Exhibit 10.27 and is incorporated herein by reference.

Item 5.07    Submission of Matters to a Vote of Security Holders.

At the Annual Meeting on June 10, 2026, the Company’s shareholders voted on the seven proposals described below.

The final voting results, including the votes used to determine the results for each proposal under the applicable approval standard (as indicated by the borders), are set forth below.

1.The shareholders elected twelve nominees as directors for a one-year term:
ForAgainstBroker
NomineeShares%Shares%AbstainNon-Votes
David P. Abney
327,624,36797.58,496,6922.5871,11755,551,812
George S. Barrett302,029,55089.934,062,78910.1899,83755,551,812
Gail K. Boudreaux
325,913,15297.010,068,7443.01,010,28055,551,812
Stephen B. Bratspies330,492,94598.35,661,2911.7837,94055,551,812
Brian C. Cornell292,419,95387.243,104,76812.81,467,45555,551,812
Robert L. Edwards326,841,94197.29,295,5892.8854,64655,551,812
Michael J. Fiddelke333,039,46499.13,038,2310.9914,48155,551,812
John R. Hoke III332,129,24498.84,015,3351.2847,59755,551,812
Christine A. Leahy297,685,71288.538,569,01511.5737,44955,551,812
Monica C. Lozano319,957,28795.216,084,6234.8950,26655,551,812
Derica W. Rice324,581,60396.511,603,9523.5806,62155,551,812
Dmitri L. Stockton320,705,04295.515,285,4854.51,001,64955,551,812

2.The shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2026:

For:Shares366,896,337 
%93.5 
Against:Shares24,917,538 
%6.3 
Abstain:Shares730,113 
%0.2 



3.The shareholders approved, on an advisory basis, the Company’s executive compensation:

For:Shares298,234,525 
%89.0 
Against:Shares36,795,522 
%11.0 
Abstain:Shares1,962,129 
Broker Non-Votes:Shares55,551,812 

4.The shareholders approved the Amended and Restated Target Corporation 2020 Long-Term Incentive Plan:

For:Shares320,173,395 
%95.0 
Against:Shares14,595,917 
%4.3 
Abstain:Shares2,222,864 
%0.7 
Broker Non-Votes:Shares55,551,812 


5.The shareholders did not approve a shareholder proposal requesting a policy requiring the Board Chair to be an independent director:

For:Shares128,544,372 
%38.1 
Against:Shares206,796,796 
%61.4 
Abstain:Shares1,651,008 
%0.5 
Broker Non-Votes:Shares55,551,812 

6.The shareholders did not approve a shareholder proposal requesting a report on presence of pesticides in Target’s private label brands:

For:Shares56,984,003 
%16.9 
Against:Shares275,003,485 
%81.6 
Abstain:Shares5,004,688 
%1.5 
Broker Non-Votes:Shares55,551,812 

7.The shareholders did not approve a shareholder proposal requesting a report on reducing plastic microfiber shedding:




For:Shares62,007,169 
%18.4 
Against:Shares270,654,883 
%80.3 
Abstain:Shares4,330,124 
%1.3 
Broker Non-Votes:Shares55,551,812 



For purposes of determining the level of support needed for a shareholder to be eligible to resubmit a shareholder proposal in a following year under Rule 14a-8 under the Securities Exchange Act of 1934, as amended, the Securities and Exchange Commission uses a simple majority standard that compares votes cast “For” to votes cast “Against” an item (which gives abstentions “No effect”). Under that simple majority standard, Item 5 received support of 38.3%, Item 6 received support of 17.2%, and Item 7 received support of 18.6%.

Item 9.01             Financial Statements and Exhibits.
 
(d)                                 Exhibits.
10.27
104Cover Page Interactive Data File (formatted as inline XBRL).




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 TARGET CORPORATION
  
Date: June 12, 2026By:/s/ Grant B. McGee
 Name: Grant B. McGee
 Title: Chief Legal and Compliance Officer and Corporate Secretary


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Target Corp (TGT)

Reference

Frequently asked questions

When did Target Corp file this 8-K?
Target Corp (TGT) filed this Current Report (Form 8-K) with the SEC on June 12, 2026. The accession number assigned by EDGAR is 0000027419-26-000026.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved the 2026 LTIP restatement and executive compensation, elected 12 directors, and rejected three shareholder proposals. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Target Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Target Corp has filed under CIK 27419, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer